1Life Healthcare

1Life Healthcare, Inc. engages in the provision of healthcare membership services. It offers walk-in immunizations and lab services, behavioral health, women's health, men’s health, LGBTQ+ care, pediatrics, sports medicine, lifestyle, and wellbeing programs. The company was founded by Thomas H. Lee on July 25, 2002 and is headquartered in San Francisco, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

One Medical is a members-only technology platform offering an array of concierge medical services. The integration of these elements allows them to offer a seamless experience that not only saves their patients time and money but also leads to better health outcomes and happier lives. The company attracts the highest caliber team of healthcare providers, allowing them to practice medicine the way it should be. Each of their professionals has the time to invest in personal relationships and engage in thoughtful decision-making with their patients. One Medical makes access to care frictionless with face-to-face virtual video visits available anytime. It allows practicing medicine the way it should be practiced, focusing on improving the patient experience and challenging the healthcare status quo. One Medical was founded in 2007 and is headquartered in San Francisco, California, United States.

AbbVie

Fate Therapeutics

Bio-Techne

Third Harmonic Bio Inc

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

5 Cheapest Health Care Stocks You Should Think About

Amazon

The already hot market of buying physician practices is about to get even hotter should Amazon's proposed acquisition of One Medical win regulatory approval.

Amazon Could Fuel Doctor Buyouts In 2023 If One Medical Deal Goes Through

Activision Blizzard

iRobot

Microsoft

Regulators and politicians are currently attempting to unravel over 40 years of antitrust precedent and replace it with an early twentieth-century approach. The new approach would reframe antitrust policy and enforcement as a political and social tool, in addition to an economic one.

Antitrust Reframed: What It Means For These Mergers

1Life Healthcare, Inc. (ONEM) delivered earnings and revenue surprises of -21.28% and 3.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

1Life Healthcare, Inc. (ONEM) Reports Q3 Loss, Lags Revenue Estimates

SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced financial results for the third quarter ended September 30, 2022.

One Medical Announces Results for Third Quarter 2022

AppLovin Corp

Enovix Corporation

NeoGenomics

Prometheus Biosciences

Signify Health

Sotera Health

Scotts Miracle-Gro

Verve Therapeutics

WeWork

Mid-cap companies are those that fall between small and large cap companies. Thus, they are more stable than small-cap companies and, at the same time, offer higher growth opportunities than large-cap companies.

These Were The Five Best And Worst Performing Mid-Cap Stocks In Q3 2022

Until the summer of 2022, most financial traders didn't spend much time thinking about 1life Healthcare (NASDAQ: ONEM ) stock. They're definitely paying attention now, though, as Amazon (NASDAQ: AMZN ) is preparing to merge with 1life Healthcare.

How to Play ONEM Stock Ahead of a Potential Amazon Deal

The Federal Trade Commission is examining Amazon's deal to purchase 1Life Healthcare for $3.9 billion, with the company operating One Medical clinics in several U.S. markets. One Medical disclosed the investigations in a securities filing, saying both companies had received a request on Friday (Sept.

Amazon's One Medical Acquisition Investigated by FTC

The Federal Trade Commission is investigating Amazon's $3.9 billion acquisition of the primary health organization One Medical, a move that could delay the completion of the deal.

FTC investigating Amazon's $3.9B purchase of One Medical

Amazon's $3.9 billion acquisition of One Medical could be delayed as the FTC asks for more information on the deal.

FTC wants more information on Amazon's One Medical purchase

WASHINGTON — The Federal Trade Commission is investigating Amazon.com Inc.'s  $3.9 billion deal to buy 1Life Healthcare Inc., which operates One Medical primary-care clinics in 25 U.S. markets.

FTC looking into Amazon's $3.9 billion deal to acquire primary-care clinic network One Medical

One Medical said on Friday the U.S. Federal Trade Commission had sought more information from the company and Amazon.com Inc over the primary care provider's $3.4-billion acquisition by the online retailer.

U.S. FTC asks Amazon, One Medical for more information on $3.4-billion deal

Vertex Pharmaceuticals

Iovance Biotherapeutics

Regeneron Pharmaceuticals

Shares of Cathie Wood's flagship exchange-traded fund (ETF), the ARK Innovation ETF (NYSEARCA: ARKK ) closed the week down about 2.5%, losing out on earlier gains during the week. However, retail investors haven't lost hope in ARKK, or Cathie Wood just yet.

5 Top Stocks Cathie Wood Is Selling This Week

Aerie Pharmaceuticals

Chemocentryx

Shift Technologies

NEW YORK , Aug. 25, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: 1Life Healthcare, Inc. (NASDAQ: ONEM)'s  sale to Amazon.com, Inc. for $18.00 per share in cash. If you are a 1Life shareholder, click here to learn more about your rights and options.

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ONEM, CCXI, AERI, SFT

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of One Medical (NasdaqGS:ONEM) to Amazon.com, Inc. (NasdaqGS: AMZN). Under the terms of the proposed transaction, shareholders of One Medical will receive $18.00 for each share of One Medical that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whet

ONE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of One Medical - ONEM

Amazon plans to spend billions of dollars on two gigantic acquisitions: iRobot and One Medical. If approved, Amazon could gather data Roomba collects from mapping floor plans and more.

Amazon sparks more privacy concerns after offering billions to acquire iRobot, One Medical

A new regulatory filing details Amazon's behind-the-scenes talks for One Medical, leading up to the Seattle tech giant's agreement to acquire the primary care company for $3.

How Amazon's mandate against media leaks helped to seal its $3.9B deal to acquire One Medical

NEW ORLEANS , Aug. 10, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

ONE MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of One Medical -ONEM

Rivian Automotive

Both 1Life Healthcare and Rivian have benefited from news relating to Amazon last month.

2 Growth Stocks That Soared More Than 30% in July

Hanger Inc

Meridian Bioscience

NEW YORK , Aug. 8, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Meridian Bioscience, Inc. (NASDAQ: VIVO) 's  sale to SD Biosensor, Inc. and SJL Partners LLC for $34.00 per share in cash. If you are a Meridian shareholder, click here to learn more about your rights and options.

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, ONEM, HNGR

Amazon's latest move shows that the e-commerce leader is very serious about making its mark on the healthcare arena.

Here's What Investors Should Know About Amazon's Potential Acquisition of One Medical

1Life Healthcare, Inc. (ONEM) delivered earnings and revenue surprises of 0% and 3.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

1Life Healthcare, Inc. (ONEM) Reports Q2 Loss, Misses Revenue Estimates

SAN FRANCISCO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced financial results for the second quarter ended June 30, 2022.

One Medical Announces Results for Second Quarter 2022

Will consumers order up healthcare through Amazon Prime as easily as they stream The Boys or buy an Echo speaker?

Prime healthcare: How Amazon's $3.9B One Medical deal could boost its subscription program

Teladoc

Between subpar earnings and Amazon's potential purchase of One Medical, Teladoc investors have their hands full of late.

News for 1Life Healthcare Stock (ONEM)